A
Amar Balihodžić
Publications - 5
Citations - 20
Amar Balihodžić is an academic researcher. The author has contributed to research in topics: Medicine & Cancer. The author has co-authored 1 publications.
Papers
More filters
Journal ArticleDOI
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Amar Balihodžić,Felix Prinz,Michael A. Dengler,George A. Calin,Philipp J. Jost,Martin Pichler +5 more
TL;DR: In this article , a review of ncRNAs implicated in the regulation of ferroptosis in cancer and highlights their underlying molecular mechanisms in the light of potential therapeutic applications is presented.
Journal ArticleDOI
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery
Georg C. Hutterer,Johannes Mischinger,Maximilian Seles,Renate Pichler,Sebastian Mannweiler,Amar Balihodžić,Jasmin Spiegelberg,Thomas Bauernhofer,Sascha Ahyai,Richard Zigeuner,Martin Pichler,Dominik A. Barth +11 more
TL;DR: In this article , the authors evaluated the prognostic value of the Fibrinogen/C-reactive protein (FC)-score in a cohort of surgically treated urothelial carcinoma patients.
Journal ArticleDOI
Impact of Diuretics on Metabolic Activity of Urogenital Tract Microbiota in Women
Journal ArticleDOI
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response
Felix Prinz,Katharina Jonas,Amar Balihodžić,Christiane Klec,Andreas Reicher,Dominik A. Barth,Jakob M. Riedl,Armin Gerger,Tobias Kiesslich,Christian Mayr,Beate Rinner,Julia Kargl,Martin Pichler +12 more
TL;DR: In this article , the miR-200c-3p mimic triggered a double-stranded (ds)RNA-dependent antiviral response, which had substantial cellular consequences including an induction of interferon type I and type III expression, increased levels of intracellular dsRNA sensors, and a significantly altered cellular growth and apoptotic activity.
Journal ArticleDOI
The Effectiveness of Cancer Immune Checkpoint Inhibitor Retreatment and Rechallenge—A Systematic Review
Adrian Perdyan,Bartosz Kamil Sobocki,Amar Balihodžić,A. Dabrowska,Justyna Kacperczyk,Jacek Rutkowski +5 more
TL;DR: In this article , a systematic review gathered recent findings on immune checkpoint inhibitor retreatment or rechallenge in order to overcome primary resistance, and identified 15 studies in which at least one parameter (overall response rate or disease control rate) improved or was stable at secondary treatment.